Raúl de Pablo Sánchez-rekin lankidetzan egindako argitalpenak (12)

2023

  1. Early routine use of V-A ECMO in patients with myocardial infarction and cardiogenic shock, is it a poor choice?

    Medicina Intensiva

  2. Reply to “Pulmonary aspergillosis in the intensive care unit: An underdiagnosed disease?”

    Medicina Intensiva

2022

  1. Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study

    Intensive Care Medicine, Vol. 48, Núm. 6, pp. 690-705

  2. Co-infection and ICU-acquired infection in COIVD-19 ICU patients: a secondary analysis of the UNITE-COVID data set

    Critical Care, Vol. 26, Núm. 1

  3. Compassionate use of cefiderocol to treat tissue infection caused by MDR-pseudomonas aeruginosa in a critically-ill patient

    Revista Chilena de Anestesia, Vol. 51, Núm. 2, pp. 213-216

  4. Correction to: Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study (Intensive Care Medicine, (2022), 48, 6, (690-705), 10.1007/s00134-022-06705-1)

    Intensive Care Medicine

  5. Correction: Co-infection and ICU-acquired infection in COVID-19 ICU patients: a secondary analysis of the UNITE-COVID data set (Critical Care, (2022), 26, 1, (236), 10.1186/s13054-022-04108-8)

    Critical Care

  6. Quantitative pupillometry as a tool to predict post-cardiac arrest neurological outcome in target temperature patients

    Medicina Intensiva

  7. Should we abandon target temperature management at 33°C in post cardiac arrest patients?

    Medicina Intensiva

  8. The value of the intensivist in the intensive care unit

    Medicina Intensiva

2021

  1. Prognosis of patients with critical hepatic disease

    Revista Chilena de Anestesia, Vol. 50, Núm. 3, pp. 463-471

  2. The right care at the right place with the right specialist

    The Lancet Regional Health - Western Pacific